(1)
ter Haar, E. L. M.; van den Reek, J. M. P. A.; Gaarn Du Jardin, K.; Barbero-Castillo, A.; de Jong, E. M. G. J. .; Lubeek, S. F. K. . Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and ReSURFACE 2) Through 244 Weeks. Acta Derm Venereol 2023, 103, adv17752.